Plant-based vaccine: Mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challenge

Infection and Immunity

Volumn 73, Issue 12, 2005, Pages 8266-8274

  Koya, Vijay ^a   Moayeri, Mahtab ^b   Leppla, Stephen H ^b   Daniell, Henry ^a  

^a UNIVERSITY OF CENTRAL FLORIDA   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX LETHAL FACTOR; ANTHRAX VACCINE; BACTERIAL ANTIGEN; BACTERIAL TOXIN; EDEMA FACTOR; IMMUNOLOGICAL ADJUVANT; PROTECTIVE ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTHRAX; ANTIGEN EXPRESSION; ARTICLE; BACILLUS ANTHRACIS; BACTERIUM CULTURE; CHLOROPLAST; CONTROLLED STUDY; CYTOLYSIS; DRUG CYTOTOXICITY; DRUG SAFETY; FEMALE; GENE; GENE INSERTION; GENOME; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; IMMUNOGLOBULIN PRODUCTION; INFECTION PREVENTION; MACROPHAGE; MOUSE; NONHUMAN; PAGA GENE; PLANT LEAF; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; SOUTHERN BLOTTING; SUPERNATANT; TOBACCO; TRANSGENE; TRANSGENIC PLANT;

ANIMALS; ANTHRAX; ANTHRAX VACCINES; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; BLOTTING, SOUTHERN; CHLOROPLASTS; IMMUNE SERA; IMMUNIZATION; IMMUNOBLOTTING; IMMUNOGLOBULIN G; MACROPHAGES; MICE; MICE, INBRED BALB C; PLANT LEAVES; PLANTS, GENETICALLY MODIFIED; TOBACCO;

EID: 28444439874     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.12.8266-8274.2005     Document Type: Article

References (32)

1. Ascenzi, P., P. Visca, G. Ippolito, A. Spallarossa, M. Bolognesi, and C. Montecucco. 2002. Anthrax toxin: a tripartite lethal combination. FEBS Lett. 531:384-388.
2. Audibert, F. 2003. Adjuvants for vaccines, a quest. Int. Immunopharmacol. 3:1187-1193.
3. Aziz, M. A., S. Singh, P. Anand Kumar, and R. Bhatnagar. 2002. Expression of protective antigen in transgenic plants: a step towards edible vaccine against anthrax. Biochem. Biophys. Res. Commun. 299:345-351.
4. Cohen, S., I. Mendelson, Z. Altboum, D. Kobiler, E. Elhanany. T. Bino, M. Leitner, I. Inbar, H. Rosenberg, Y. Gozes, R. Barak. M. Fisher, C. Kronman, B. Velan, and A. Shafferman. 2000. Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax. Infect. Immun. 68:4549-4558.
5. Collier, R. J., and J. A. Young. 2003. Anthrax toxin. Annu. Rev. Cell Dev. Biol. 19:45-70.
6. Coulson, N. M., M. Fulop, and R. W. Titball. 1994. Bacillus anthracis protective antigen, expressed in Salmonella typhimurium SL 3261, affords protection against anthrax spore challenge. Vaccine 12:1395-1401.
7. Cramer, C. L., J. G. Boothe, and K. K. Oishi. 1999. Transgenic plants for therapeutic proteins: linking upstream and down stream strategies. Curr. Top. Microbiol. Immunol. 240:95-118.
8. Daniell, H. 2002. Molecular strategies for gene containment in transgenic crops. Nat. Biotechnol. 20:581-587.
9. Daniell, H., A. Dhingra, and O. N. Ruiz. 2004. Chloroplast genetic engineering to confer desired plant traits. Methods Mol. Biol. 286:111-137.
10. Daniell, H., S. B. Lee, T. Panchal, and P. O. Wiebe. 2001. Expression of cholera toxin B subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts. J. Mol. Biol. 311:1001-1009.
11. DeCosa, B., W. Moar, S. B. Lee, M. Miller, and H. Daniell. 2001. Overexpression of the Btcry2Aa2 operon in chloroplasts leads to formation of insecticidal crystals. Nat. Biotechnol. 19:71-74.
12. Fernandez-San Millan, A., A. M. Mingeo-Castel, M. Miller, and H. Daniell. 2003. A chloroplast transgenic approach to hyper-express and purify human serum albumin, a protein highly susceptible to proteolytic degradation. Plant Biotechnol. J. 1:71-79.
13. Gaur, R., P. K. Gupta, A. C. Banerjea. and Y. Singh. 2002. Effect of nasal immunization with protective antigen of Bacillus anthracis on protective immune response against anthrax toxin. Vaccine 20:2836-2839.
14. Geier, D. A., and R. M. Geier. 2002. Anthrax vaccination and joint related adverse reactions in light of biological warfare scenarios. Clin. Exp. Rheumatol. 20:217-220.
15. Gupta, P., S. M. Waheed, and R. Bhatnagar. 1999. Expression and purification of the recombinant protective antigen of Bacillus anthracis. Protein Expr. Purif. 16:369-376.
16. Hanna, P. C., D. Acosta, and R. J. Collier. 1993. On the role of macrophages in anthrax. Proc. Natl. Acad. Sci. USA 90:10198-10201.
17. Kaufmann, A. F., M. I. Meltzer, and G. P. Schmid. 1997. The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable? Emerg. Infect. Dis. 3:83-94.
18. Kumar, S., A. Dhingra, and H. Daniell. 2004. Plastid-expressed betainealdehyde dehydrogenase gene in carrot cultured cells, roots, and leaves confers enhanced salt tolerance. Plant Physiol. 136:2843-2854.
19. Leppla, S. H., J. B. Robbins, R. Schneersan, and J. Shiloach. 2002. Development of an improved vaccine for anthrax. J. Clin. Investig. 109:141-144.
20. McBride, B. W., A, Mogg, J. L. Telfer, M. S. Lever, J. Miller, P. C. Turnbull, and L. Baillie. 1998. Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers. Vaccine 16:810-817.
21. Miller, J., B. W. McBride, R. J. Manchee, P. Moore, and L. W. J. Baillie. 1998. Production and purification of recombinant protective antigen and protective efficacy against Bacillus anthracis. Lett. Appl. Microbiol. 26:56-60.
22. Moayeri, M., N. W. Martinez, J. Wiggins, H. A. Young, and S. H. Leppla. 2004. Mouse susceptibility to anthrax lethal toxin is influenced by genetic factors in addition to those controlling macrophage sensitivity. Infect. Immun. 72:4439-4441.
23. Molina, A., S. Herva-Stubbs, H. Daniell, A. M, Mingo-Castel, and J. Veramendi. 2004. High yield expression of a viral peptide animal vaccine in transgenic tobacco chloroplasts. Plant Biotechnol. J. 2:141-153.
24. Quesada-Vargas, T., O. N. Ruiz, and H. Daniell. 2005. Characterization of heterologous multigene operons in transgenic chloroplasts: transcription, processing, translation. Plant Physiol. 138:1746-1762.
25. Quinn, C. P., V. A. Semenova, C. M. Elie, S. Romero-Steiner, C. Greene et al. 2002. Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen. Emerg. Infect. Dis. 8:1103-1110.
26. Ramirez, D. M., S. H. Leppla, R. Schneerson, and J. Shiloach. 2002. Production, recovery and immunogenicity of the protective antigen from a recombinant strain of Bacillus anthracis. J. Ind. Microbiol. Biotechnol. 28: 232-238.
27. Ruiz, O. N., and H. Daniell. 2005. Engineering cytoplasmic male sterility via the chloroplast genome. Plant Physiol. 138:1232-1246.
28. Ruiz, O. N., H. Hussein, N. Terry, and H. Daniell. 2003. Phytoremediation of organomercurial compounds via chloroplast genetic engineering. Plant Physiol. 132:1344-1352.
29. Sever, J. L., A. I. Brenner, A. D. Gale, J. M. Lyle, L. H. Moulton et al. 2002. Safety of anthrax vaccine: a review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). Pharmacoepidemiol. Drug Saf. 11:189-202.
30. Watson, J., V. Koya, S. H. Leppla, and H. Daniell. 2004. Expression of Bacillus anthracis protective antigem in transgenic chloroplasts of tobacco, a non-food/feed crop. Vaccine 22:4374-4384.
31. Whiting, G. C., S. Rijpkema, T. Adams and M. J. Corbel. 2004. Characterisation of adsorbed anthrax vaccine by two-dimensional gel electrophoresis. Vaccine 22:4245-4251.
32. Zegers, N. D., E. Kluter, H. van Der Stap, E. van Dura, P. van Dalen, M. Shaw, and L. Baillie. 1999. Expression of the protective antigen of Bacillus anthracis by Lactobacillus casei; towards the development of an oral vaccine against anthrax. J. Appl. Microbiol. 87:309-314.